Physician profile
Rosana Millos
NPI 1417999798
$457.35
in general payments reported to CMS, 2019-2025
16 companies · $190 in 2025
The $190 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $192 · 2020: $74.86 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $190.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $60.36 | 2025 | |
| Antares Pharma, INC. | $51.46 | 2025 | Xyosted |
| Glaxosmithkline, LLC. | $48.98 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $42.19 | 2019-2020 | |
| Abbott Laboratories | $36.67 | 2019-2025 | Freestyle Libre |
| Teva Pharmaceuticals USA, INC. | $36.53 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $23.32 | 2019-2020 | |
| Tandem Diabetes Care, INC. | $23.11 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Novartis Pharmaceuticals Corporation | $22.40 | 2019 | |
| Amgen INC. | $21.28 | 2019 | |
| Xeris Pharmaceuticals, INC. | $19.60 | 2025 | Recorlev |
| Amarin Pharma, INC. | $17.03 | 2020 | |
| Lilly USA, LLC | $14.70 | 2019 | |
| Allergan, INC. | $14.49 | 2020 | |
| Novo Nordisk INC | $13.11 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beta Bionics, INC. | $12.12 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rosana Millos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.